样式: 排序: IF: - GO 导出 标记为已读
-
Risk of COVID-19 Hospitalization and Protection Associated With mRNA Vaccination Among US Adults With Psychiatric Disorders Influenza Other Respir. Viruses (IF 4.4) Pub Date : 2024-03-17 Matthew E. Levy, Duck-Hye Yang, Margaret M. Dunne, Kathleen Miley, Stephanie A. Irving, Shaun J. Grannis, Zachary A. Weber, Eric P. Griggs, Talia L. Spark, Elizabeth Bassett, Peter J. Embi, Manjusha Gaglani, Karthik Natarajan, Nimish R. Valvi, Toan C. Ong, Allison L. Naleway, Edward Stenehjem, Nicola P. Klein, Ruth Link-Gelles, Malini B. DeSilva, Anupam B. Kharbanda, Chandni Raiyani, Maura A. Beaton
Although psychiatric disorders have been associated with reduced immune responses to other vaccines, it remains unknown whether they influence COVID-19 vaccine effectiveness (VE). This study evaluated risk of COVID-19 hospitalization and estimated mRNA VE stratified by psychiatric disorder status.
-
Respiratory Syncytial Virus‐Associated Hospitalizations in Children: A 10‐Year Population‐Based Analysis in Finland, 2008–2018 Influenza Other Respir. Viruses (IF 4.4) Pub Date : 2024-03-13 Erika Uusitupa, Matti Waris, Tytti Vuorinen, Terho Heikkinen
BackgroundThe risk of respiratory syncytial virus (RSV) hospitalization is highest during the first months of life, but few studies have assessed the population‐based rates of hospitalization in monthly age groups of infants.MethodsWe determined the average population‐based rates of hospitalization with virologically confirmed RSV infections in children ≤15 years of age admitted during the 10‐year
-
Real‐Life Comparison of Antivirals for SARS‐CoV‐2 Omicron Infection in Patients With Hematologic Malignancies Influenza Other Respir. Viruses (IF 4.4) Pub Date : 2024-03-12 Tommaso Francesco Aiello, Olivier Peyrony, Mariana Chumbita, Patricia Monzó, Carlos Lopera, Pedro Puerta‐Alcalde, Laura Magnano, Francesc Fernández‐Avilés, Genoveva Cuesta, Montse Tuset, Josep Mensa, Jordi Esteve, Maria Angeles Marcos, Alex Soriano, Carolina Garcia‐Vidal
BackgroundWe aimed to describe a cohort of hematologic patients with COVID‐19 treated with antivirals early.MethodsNon‐interventional chart review study. Comparison of baseline characteristics and outcomes in high‐risk hematologic patients treated with remdesivir between December 2021 and April 2022 versus those treated with nirmatrelvir/ritonavir between May and August 2022.ResultsEighty‐three patients
-
Bidirectional Evolution of SARS‐CoV‐2 Virus in Immunocompromised Hosts Influenza Other Respir. Viruses (IF 4.4) Pub Date : 2024-03-11 Charmaine W. Y. Chew, Barnaby E. Young, Paul A. Tambyah, Shawn Vasoo, Conrad E. Z. Chan
To the editor: SARS-CoV-2 has accumulated significant mutations to evade both vaccine- and infection-induced immunity. Some of the currently dominant Omicron subvariants are thought to have initially evolved in immunocompromised patients despite the lack of selection pressure from the host immune response or poor vaccine response [1]. Interestingly, some of these mutations such as K417N and F486S have
-
Rapid PCR Testing Reduces Antibiotic Prescribing in Children Presenting to Hospital With Lower Respiratory Tract Infections due to Influenza Influenza Other Respir. Viruses (IF 4.4) Pub Date : 2024-02-29 Tony Walls, Emily Bowen, Ava Elsmore, Nathanael Lucas
Dear Sir/Madam We have previously demonstrated that in young children with lower respiratory tract infections (LRTI) admitted to hospital, identifying a virus on multiplex PCR testing of nasopharyngeal swabs (NPS) can lead to a reduction in antibiotic usage [1]. Rapid availability of viral PCR test results appears to provide additional antimicrobial stewardship benefits and can further reduce unnecessary
-
Issue Information Influenza Other Respir. Viruses (IF 4.4) Pub Date : 2024-02-27
No abstract is available for this article.
-
Vaccine effectiveness against influenza hospitalisation in adults during the 2022/2023 mixed season of influenza A(H1N1)pdm09, A(H3N2) and B circulation, Europe: VEBIS SARI VE hospital network Influenza Other Respir. Viruses (IF 4.4) Pub Date : 2024-02-25 Angela M. C. Rose, Francisco Pozo, Iván Martínez-Baz, Clara Mazagatos, Nathalie Bossuyt, John Paul Cauchi, Goranka Petrović, Isabela I. Loghin, Roberta Vaikutyte, Silke Buda, Ausenda Machado, Róisín Duffy, Beatrix Oroszi, Jennifer Howard, Aitziber Echeverria, Cristina Andreu, Cyril Barbezange, Aušra Džiugytė, Diana Nonković, Corneliu-Petru Popescu, Fausta Majauskaite, Kristin Tolksdorf, Verónica Gomez
We conducted a multicentre hospital-based test-negative case–control study to measure vaccine effectiveness (VE) against PCR-confirmed influenza in adult patients with severe acute respiratory infection (SARI) during the 2022/2023 influenza season in Europe. Among 5547 SARI patients ≥18 years, 2963 (53%) were vaccinated against influenza. Overall VE against influenza A(H1N1)pdm09 was 11% (95% CI: −23–36);
-
Evolutionary analysis of seasonal influenza A viruses in Pakistan 2020–2023 Influenza Other Respir. Viruses (IF 4.4) Pub Date : 2024-02-22 Nazish Badar, Aamer Ikram, Muhammad Salman, Sidra Saeed, Hamza Ahmed Mirza, Abdul Ahad, Massab Umair, Umer Farooq
Influenza A viruses cause global health concerns due to their high amino acid substitution rates. They are linked to yearly seasonal epidemics and occasional pandemics. This study focused on sequencing influenza A virus strains in Pakistan.
-
An algorithm for the characterization of influenza A viruses from various host species and environments Influenza Other Respir. Viruses (IF 4.4) Pub Date : 2024-02-22 Laura A. Pulscher, Richard J. Webby, Gregory C. Gray
Due to the extensive host range of influenza A viruses, it is difficult to determine the best diagnostic algorithm to efficiently screen samples from a variety of host species for influenza A viruses. While there are some influenza diagnostic algorithms that are specific to host species, to our knowledge, no single algorithm exists for the characterization of influenza A viruses across multiple host
-
WHO's Investigations and Studies, Unity Studies: A global initiative creating equitable opportunities for enhanced surveillance, operational research, capacity building, and global knowledge sharing Influenza Other Respir. Viruses (IF 4.4) Pub Date : 2024-02-12 Isabel Bergeri, Nicki L. Boddington, Hannah C. Lewis, Lorenzo Subissi, Sophie von Dobschuetz, Angel Rodriguez, Jorge Jara, Hala Abou El Naja, Amal Barakat, Arash Rashidian, Eman Abdelkreem Aly, Lubna Al Ariqi, Pushpa Wijesinghe, Francis Inbanathan, Phuong Nam Nguyen, Manilay Phengxay, Linh-Vi Le, Temuulen Enebish, Joseph Okeibunor, Belinda Herring, Elise Farley, Pernille Jorgensen, Aisling Marie Vaughan
The World Health Organization's Unity Studies global initiative provides a generic preparedness and readiness framework for conducting detailed investigations and epidemiological studies critical for the early and ongoing assessment of emerging respiratory pathogens of pandemic potential. During the COVID-19 pandemic, the initiative produced standardized investigation protocols and supported Member
-
Role of research Laboratories in pandemic and epidemic response in the Eastern Mediterranean Region: Experiences from COVID-19, avian influenza, and MERS-CoV Influenza Other Respir. Viruses (IF 4.4) Pub Date : 2024-02-11 Mona Mahmoud, Rebecca Badra, Ahmed Kandeil, Rabeh El-Shesheny, Jad Abdallah, Mohamed A. Ali, Ghazi Kayali
We share the experience of research laboratories in the Eastern Mediterranean Region (EMR) that contributed to preparedness and response to highly pathogenic avian influenza (HPAI), Middle-East respiratory syndrome coronavirus (MERS-CoV), and coronavirus disease (COVID-19). Research groups in the region were pivotal in identifying, characterizing the pathogens and describing their evolution, distribution
-
High seroprevalence of severe acute respiratory syndrome coronavirus 2 among healthcare workers in Yaoundé, Cameroon after the first wave of Covid-19 pandemic and associated factors Influenza Other Respir. Viruses (IF 4.4) Pub Date : 2024-02-11 Mathurin Cyrille Tejiokem, Hermine Abessolo Abessolo, Joseph Mendimi Nkodo, Mireille Ouethy, Georges Bouting Mayaka, Yannick Touha, Ulrich Armel Dikoume, Jules Brice Tchatchueng-Mbougua, Diane Choualeu Noumbissi, William Tsobeng Ndjeukam, Hervé Odilon Otabela Mbarga, Paul Alain Tagnouokam Ngoupo, Charlotte Moussi, Bonaventure Hollong Garoua, Richard Njouom, Vincent Richard
Healthcare workers (HWs) are at a high risk of exposure to emerging health threats. Following the first wave of the coronavirus disease 2019 pandemic in Cameroon, we explored the presence and persistence of naturally acquired antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the factors associated with seropositivity in HWs.
-
Functional decline at 1 year in hospitalized elderly pneumonia with SARS-CoV-2 Omicron variant: Comparison with the ancestral strain and Alpha variant Influenza Other Respir. Viruses (IF 4.4) Pub Date : 2024-02-07 Naoyuki Miyashita, Yasushi Nakamori, Makoto Ogata, Naoki Fukuda, Akihisa Yamura, Tomoki Ito
In the SARS-CoV-2 Omicron period, the pattern of pneumonia changed from primarily viral pneumonia to pneumonia mixed with bacteria in the elderly. We investigated functional outcomes at 1 year after hospital discharge in patients with primary Omicron pneumonia and pneumonia mixed with bacteria, mainly aspiration pneumonia. Functional decline rates calculated using the Barthel Index at 1 year after
-
A phased strengthening of laboratory capacity in the Eastern Mediterranean Region during the COVID-19 pandemic Influenza Other Respir. Viruses (IF 4.4) Pub Date : 2024-02-05 Luke W. Meredith, Mustafa Aboualy, Rachel Ochola, Mehmet Ozel, Abdinasir Abubakar, Amal Barakat
The Eastern Mediterranean Region (EMR) faces ongoing challenges in its public health system due to limited resources, logistical issues, and political disruptions. The COVID-19 pandemic accelerated the need for stronger laboratory capacities to handle the increased demand for testing. In a phased response, EMR countries utilized the National Influenza Centers to rapidly establish and scale molecular
-
The respiratory syncytial virus prefusion F protein vaccine attenuates the severity of respiratory syncytial virus-associated disease in breakthrough infections in adults ≥60 years of age Influenza Other Respir. Viruses (IF 4.4) Pub Date : 2024-02-03 Desmond Curran, Sean Matthews, Eliazar Sabater Cabrera, Silvia Narejos Pérez, Lina Pérez Breva, Mika Rämet, Laura Helman, Dae Won Park, Tino F. Schwarz, Isabel Maria Galan Melendez, Axel Schaefer, Nathalie Roy, Brigitte Stephan, Daniel Molnar, Lusine Kostanyan, John H. Powers, Veronica Hulstrøm
-
Respiratory viral detection in the plasma and cerebrospinal fluid (CSF) of young febrile infants Influenza Other Respir. Viruses (IF 4.4) Pub Date : 2024-02-01 Erin G. Nicholson, Vasanthi Avadhanula, Leila C. Sahni, Laura Ferlic-Stark, Lauren Maurer, Julie A. Boom, Pedro A. Piedra
Respiratory viral infections are common in febrile infants ≤90 days. However, the detection of viruses other than enterovirus in the blood and cerebrospinal fluid (CSF) of young infants is not well defined. We sought to quantify the occurrence of respiratory viruses in the blood and CSF of febrile infants ≤90 days.
-
Issue Information Influenza Other Respir. Viruses (IF 4.4) Pub Date : 2024-01-30
No abstract is available for this article.
-
Internationally standardized respiratory viral load testing with limited resources: A derivative-of-care calibration strategy for SARS-CoV-2 Influenza Other Respir. Viruses (IF 4.4) Pub Date : 2024-01-23 Lili Tao, Allison Chan, Alex Maris, Jonathan E. Schmitz
SARS-CoV-2 has demonstrated that, in targeted circumstances, viral quantification within respiratory specimens can valuably inform patient management, as well as research. Nevertheless, the pandemic has illustrated concomitant challenges for obtaining high-quality (and broadly comparable) respiratory viral loads. This includes a critical need for standardization and calibration, even though the necessary
-
Comparison of influenza viral load in nasopharyngeal and midturbinate swabs Influenza Other Respir. Viruses (IF 4.4) Pub Date : 2024-01-21 Corrado Bernasconi, Laurie Katugampola, Steffen Wildum
Different specimen types are used for influenza diagnosis but comparative data for viral loads from different swab types are limited. We compared influenza viral loads (determined by quantitative reverse transcription polymerase chain reaction [RT-PCR]) in 93 paired midturbinate and nasopharyngeal swab aliquots from influenza infected patients enrolled in a phase 3 randomized-controlled study with
-
Quantified impacts of non-pharmaceutical interventions on influenza circulation during the COVID-19 pandemic in 13 African countries, 2020–2022 Influenza Other Respir. Viruses (IF 4.4) Pub Date : 2024-01-18 Radhika Gharpure, Sonja J. Olsen, William W. Davis
Nonpharmaceutical interventions (NPIs) for SARS-CoV-2 disrupted circulation of influenza. We used data from 13 African countries and generalized linear models to identify associations between levels of NPIs, using the Oxford Stringency Index, and seasonal influenza activity, using parameters derived from 2020–2022 seasonal influenza surveillance. We found that for each step increase in school closings
-
Comparative analysis of mortality in patients admitted with an infection with influenza A/B virus, respiratory syncytial virus, rhinovirus, metapneumovirus or SARS-CoV-2 Influenza Other Respir. Viruses (IF 4.4) Pub Date : 2024-01-18 Hanneke Boon, Arend-Jan Meinders, Erik Jan van Hannen, Matthijs Tersmette, Erik Schaftenaar
While influenza virus and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are recognised as a cause of severe illness and mortality, clinical interest for respiratory syncytial virus (RSV), rhinovirus and human metapneumovirus (hMPV) infections is still limited.
-
Respiratory syncytial virus among hospitalized patients of severe acute respiratory infection in Bhutan: Cross-sectional study Influenza Other Respir. Viruses (IF 4.4) Pub Date : 2024-01-17 Kunzang Dorji, Pema Yuden, Tara Devi Ghishing, Govinda Ghimeray, Chonticha Klungthong, Sonam Wangchuk, Aaron Farmer
Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infections worldwide, particularly in young children. In Bhutan, respiratory disease continues to be among the top 10 diseases of morbidity for several years. This study aimed to estimate the prevalence of RSV among hospitalized patients with severe acute respiratory infection (SARI) in Bhutan.
-
Effect of planned school breaks on student absenteeism due to influenza-like illness in school aged children—Oregon School District, Wisconsin September 2014–June 2019 Influenza Other Respir. Viruses (IF 4.4) Pub Date : 2024-01-16 Cecilia He, Derek Norton, Jonathan L. Temte, Shari Barlow, Maureen Goss, Emily Temte, Cristalyne Bell, Guanhua Chen, Amra Uzicanin
School-aged children and school reopening dates have important roles in community influenza transmission. Although many studies evaluated the impact of reactive closures during seasonal and pandemic influenza outbreaks on medically attended influenza in surrounding communities, few assess the impact of planned breaks (i.e., school holidays) that coincide with influenza seasons, while accounting for
-
Relevance of comorbidities for main outcomes during different periods of the COVID-19 pandemic Influenza Other Respir. Viruses (IF 4.4) Pub Date : 2024-01-16 José M. Quintana-Lopez, Lander Rodríguez, Janire Portuondo, Julia García, Maria Jose Legarreta, María Gascón, Nere Larrea, Irantzu Barrio
Throughout the evolution of the COVID-19 pandemic, the severity of the disease has varied. The aim of this study was to determine how patients' comorbidities affected and were related to, different outcomes during this time.
-
Influenza vaccine effectiveness in Europe: Results from the 2022–2023 VEBIS (Vaccine Effectiveness, Burden and Impact Studies) primary care multicentre study Influenza Other Respir. Viruses (IF 4.4) Pub Date : 2024-01-10 Marine Maurel, Francisco Pozo, Gloria Pérez-Gimeno, Silke Buda, Noémie Sève, Beatrix Oroszi, Mariette Hooiveld, Verónica Gomez, Lisa Domegan, Iván Martínez-Baz, Maja Ilić, Anna Sara Carnahan, Maria Elena Mihai, Ana Martínez, Luise Goerlitz, Vincent Enouf, Judit Krisztina Horváth, Frederika Dijkstra, Ana Paula Rodrigues, Charlene Bennett, Camino Trobajo-Sanmartín, Ivan Mlinarić, Neus Latorre-Margalef
Influenza A(H3N2) viruses dominated early in the 2022–2023 influenza season in Europe, followed by higher circulation of influenza A(H1N1)pdm09 and B viruses. The VEBIS primary care network estimated the influenza vaccine effectiveness (VE) using a multicentre test-negative study.
-
Surveillance of seasonal influenza viruses during the COVID-19 pandemic in Tokyo, Japan, 2018–2023, a single-center study Influenza Other Respir. Viruses (IF 4.4) Pub Date : 2024-01-05 Hidenori Takahashi, Hiroki Nagamatsu, Yuka Yamada, Naoya Toba, Mio Toyama-Kousaka, Shinichiro Ota, Miwa Morikawa, Masahiro Shinoda, Syunsuke Takano, Suzuko Fukasawa, Kaeyoung Park, Takahiko Yano, Masamichi Mineshita, Masaharu Shinkai
COVID-19 pandemic led to significant reductions in influenza detection worldwide, fueling debates on whether influenza truly ceased circulating in communities. The number of influenza cases decreased significantly in Japan, raising concerns about the potential risk of decreased immunity to influenza in the population. Our single-center study aimed to investigate influenza trends before and during the
-
In-field detection and characterization of B/Victoria lineage deletion variant viruses causing early influenza activity and an outbreak in Louisiana, 2019 Influenza Other Respir. Viruses (IF 4.4) Pub Date : 2024-01-05 Bo Shu, Malania M. Wilson, Matthew W. Keller, Ha Tran, Theresa Sokol, Grace Lee, Benjamin L. Rambo-Martin, Marie K. Kirby, Norman Hassell, Danielle Haydel, Julie Hand, David E. Wentworth, John R. Barnes
In 2019, the Louisiana Department of Health reported an early influenza B/Victoria (B/VIC) virus outbreak.
-
Comparison of the Oxford COVID-19 Government Response Tracker and the ECDC-JRC Response Measures Database for nonpharmaceutical interventions Influenza Other Respir. Viruses (IF 4.4) Pub Date : 2024-01-02 Susanne Heemskerk, Peter Spreeuwenberg, Harish Nair, John Paget
During the COVID-19 pandemic, governments implemented different public health measures and interventions to control COVID-19. These wide-ranging public health interventions, also known as non-pharmaceutical interventions (NPIs), have been documented in Europe in two different publicly available databases. In the context of an EU-funded research project aimed at Preparing for Respiratory Syncytial Virus
-
Issue Information Influenza Other Respir. Viruses (IF 4.4) Pub Date : 2024-01-01
No abstract is available for this article.
-
Seroprevalence of SARS-CoV-2 infection in the general population of Nepal during the first and second generalized waves of the COVID-19 pandemic—2020–2021 Influenza Other Respir. Viruses (IF 4.4) Pub Date : 2023-12-27 Krishna Prasad Paudel, Reuben Samuel, Runa Jha, Basu Dev Pandey, Chathura Edirisuriya, Nebin Lal Shrestha, Pradip Gyawali, Amrit Pokhrel, Lilee Shrestha, Ram Kumar Mahato, Shaikh Shah Hossain, Govindakarnavar Arunkumar, Anindya Sekhar Bose, Meghnath Dhimal, Dipendra Gautam, Subash Neupane, Nishant Thakur, Saugat Shrestha, Nirajan Bhusal, Priya Jha, Binod Prasad Gupta, Rajan Bikram Rayamajhi, Koshal
Few seroprevalence studies have been conducted on coronavirus disease (COVID-19) in Nepal. Here, we aimed to estimate seroprevalence and assess risk factors for infection in the general population of Nepal by conducting two rounds of sampling. The first round was in October 2020, at the peak of the first generalized wave of COVID-19, and the second round in July–August 2021, following the peak of the
-
Avian influenza A(H5) virus circulation in live bird markets in Vietnam, 2017–2022 Influenza Other Respir. Viruses (IF 4.4) Pub Date : 2023-12-27 Diep T. Nguyen, Kelsey M. Sumner, Thoa T. M. Nguyen, Minh Q. Phan, Tien M. Hoang, Chuong D. Vo, Tho D. Nguyen, Phuong T. Nguyen, Genyan Yang, Yunho Jang, Joyce Jones, Sonja J. Olsen, Philip L. Gould, Long V. Nguyen, Charles Todd Davis
Highly pathogenic avian influenza A(H5) human infections are a global concern, with many A(H5) human cases detected in Vietnam, including a case in October 2022. Using avian influenza virus surveillance from March 2017–September 2022, we described the percent of pooled samples that were positive for avian influenza A, A(H5), A(H5N1), A(H5N6), and A(H5N8) viruses in live bird markets (LBMs) in Vietnam
-
Comparison of the clinical features and outcomes of severe seasonal influenza and COVID-19 patients in Tunisia between 2021 and 2022 Influenza Other Respir. Viruses (IF 4.4) Pub Date : 2023-12-20 Jalila Ben Khelil, Rihab Yazidi, Nacef Ben Mrad, Fatma Jarraya, Emna Rachdi, Samia Ayed, Amira Jamoussi, Afif Ben Salah, Mohamed Besbes
We compared patients diagnosed at a SARI (severe acute respiratory infections) surveillance site with COVID-19 and those with seasonal influenza to investigate the clinical differences, common features, and outcomes.
-
Sex differences in COVID-19 symptom severity and trajectories among ambulatory adults Influenza Other Respir. Viruses (IF 4.4) Pub Date : 2023-12-19 Samuel P. Massion, Amanda C. Howa, Yuwei Zhu, Ahra Kim, Natasha Halasa, James Chappell, Trey McGonigle, Alexandra M. Mellis, Jessica E. Deyoe, Carrie Reed, Melissa A. Rolfes, H. Keipp Talbot, Carlos G. Grijalva
The ongoing COVID-19 pandemic has led to hundreds of millions of infections worldwide. Although differences in COVID-19 hospitalization rates between males and females have been described, many infections in the general population have been mild, and the severity of symptoms during the course of COVID-19 in non-hospitalized males and females is not well understood.
-
Performance of established disease severity scores in predicting severe outcomes among adults hospitalized with influenza—FluSurv-NET, 2017–2018 Influenza Other Respir. Viruses (IF 4.4) Pub Date : 2023-12-17 Joshua D. Doyle, Shikha Garg, Alissa C. O'Halloran, Lauren Grant, Evan J. Anderson, Kyle P. Openo, Nisha B. Alden, Rachel Herlihy, James Meek, Kimberly Yousey-Hindes, Maya L. Monroe, Sue Kim, Ruth Lynfield, Melissa McMahon, Alison Muse, Nancy Spina, Lourdes Irizarry, Salina Torres, Nancy M. Bennett, Maria A. Gaitan, Mary Hill, Charisse N. Cummings, Carrie Reed, William Schaffner, H. Keipp Talbot, Wesley
Influenza is a substantial cause of annual morbidity and mortality; however, correctly identifying those patients at increased risk for severe disease is often challenging. Several severity indices have been developed; however, these scores have not been validated for use in patients with influenza. We evaluated the discrimination of three clinical disease severity scores in predicting severe influenza-associated
-
Impact of antiviral therapy on short- and long-term outcomes of patients with chronic obstructive pulmonary disease after influenza infection Influenza Other Respir. Viruses (IF 4.4) Pub Date : 2023-12-13 Christopher Wallick, Tu My To, Stephan Korom, Henry Masters, Ning Wu, Dalia Moawad, Nicola A. Hanania
Respiratory complications often accompany influenza in patients with chronic obstructive pulmonary disease (COPD). In this retrospective study, we quantified the impact of antiviral therapy on exacerbations, healthcare resource utilization (HRU), and costs in patients with COPD across 5 influenza seasons.
-
Time trend of respiratory viruses before and during the COVID-19 pandemic in severe acute respiratory virus infection in the Sultanate of Oman between 2017 and 2022 Influenza Other Respir. Viruses (IF 4.4) Pub Date : 2023-12-13 Hanan Al Kindi, Luke William Meredith, Amina Al-Jardani, Fathima Sajina, Intisar Al Shukri, Rehan al Haj, Fatma Alyaquobi, Adil Al Wahaibi, Amal Al Maani
Severe acute respiratory illness (SARI) is a potentially lethal condition, necessitating thorough medical care. COVID-19 underscored the SARI threat, but other high-risk pathogens require monitoring alongside SARS-CoV-2. Oman instituted a comprehensive testing system to gauge the prevalence of these pathogens between 2017 and 2021, aiding resource allocation and public health responses to potential
-
Role of Laboratory in Emerging Infectious Disease Control in Iran, Pasteur Institute of Iran, and national laboratory network Influenza Other Respir. Viruses (IF 4.4) Pub Date : 2023-12-10 Ali Maleki, Ehsan Mostafavi, Mehdi Fazlalipour, Mostafa Salehi-Vaziri
Strengthening surveillance systems is a key aspect of outbreak response and was particularly important during the COVID-19 pandemic. Respiratory pathogens spread rapidly, and laboratory capacity is key to monitoring the spread. Prior to the pandemic, Iran had established a rapid response team and laboratory network to provide identification, monitoring, and detection of emerging infectious diseases
-
Modeling the impact of COVID-19 nonpharmaceutical interventions on respiratory syncytial virus transmission in South Africa Influenza Other Respir. Viruses (IF 4.4) Pub Date : 2023-12-10 Samantha J. Bents, Cécile Viboud, Bryan T. Grenfell, Alexandra B. Hogan, Stefano Tempia, Anne von Gottberg, Jocelyn Moyes, Sibongile Walaza, Chelsea Hansen, Cheryl Cohen, Rachel E. Baker
The South African government employed various nonpharmaceutical interventions (NPIs) to reduce the spread of SARS-CoV-2. Surveillance data from South Africa indicates reduced circulation of respiratory syncytial virus (RSV) throughout the 2020–2021 seasons. Here, we use a mechanistic transmission model to project the rebound of RSV in the two subsequent seasons.
-
Persistent predominance of the Victoria lineage of influenza B virus during COVID-19 epidemic in Nanchang, China Influenza Other Respir. Viruses (IF 4.4) Pub Date : 2023-12-10 Xianfeng Zhou, Ziqi Lin, Junling Tu, Chunlong Zhu, Hui Li
The sentinel hospital-based influenza-like illness (ILI) surveillance network was established in China since the 2009 H1N1 pandemic. This network plays important roles in monitoring influenza virus variation and identifying novel respiratory pathogens. In this study, we characterized the pathogen spectrum pattern (PSP) of ILI based on three sentinel hospitals and analyzed the significant change of
-
Acute respiratory infections among individuals seeking outpatient care in the states of Washington and Michigan by pregnancy status, 2011–2016 Influenza Other Respir. Viruses (IF 4.4) Pub Date : 2023-12-06 Collrane Frivold, Denise J. McCulloch, Seda Ekici, Emily T. Martin, Michael L. Jackson, Helen Y. Chu
Acute respiratory infections (ARIs) during pregnancy are associated with poor maternal and fetal outcomes.
-
Issue Information Influenza Other Respir. Viruses (IF 4.4) Pub Date : 2023-12-03
No abstract is available for this article.
-
Tracking severe acute respiratory syndrome coronavirus 2 transmission and co-infection with other acute respiratory pathogens using a sentinel surveillance system in Rift Valley, Kenya Influenza Other Respir. Viruses (IF 4.4) Pub Date : 2023-11-29 Vincent Kiplangat Ruttoh, Samwel Lifumo Symekher, Janet Masitsa Majanja, Silvanos Mukunzi Opanda, Esther Wanguche Chitechi, Meshack Wadegu, Ronald Tonui, Peter Kipkemboi Rotich, Tonny Teya Nyandwaro, Anne Wanjiru Mwangi, Ibrahim Ndungu Mwangi, Robert Momanyi Oira, Audrey Gwazima Musimbi, Samson Muuo Nzou
The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been the most significant public health challenge in over a century. SARS-CoV-2 has infected over 765 million people worldwide, resulting in over 6.9 million deaths. This study aimed to detect community transmission of SARS-CoV-2 and monitor the co-circulation of SARS-CoV-2 with other acute respiratory pathogens in Rift
-
Monitoring COVID-19 vaccine effectiveness against COVID-19 hospitalisation and death using electronic health registries in ≥65 years old population in six European countries, October 2021 to November 2022 Influenza Other Respir. Viruses (IF 4.4) Pub Date : 2023-11-28 Irina Kislaya, Alexis Sentís, Jostein Starrfelt, Baltazar Nunes, Iván Martínez-Baz, Katrine Finderup Nielsen, Ala'a AlKerwi, Toon Braeye, Mario Fontán-Vela, Sabrina Bacci, Hinta Meijerink, Jesús Castilla, Hanne-Dorthe Emborg, Christian Holm Hansen, Susanne Schmitz, Izaak Van Evercooren, Marta Valenciano, Anthony Nardone, Nathalie Nicolay, Susana Monge
Within the ECDC-VEBIS project, we prospectively monitored vaccine effectiveness (VE) against COVID-19 hospitalisation and COVID-19-related death using electronic health registries (EHR), between October 2021 and November 2022, in community-dwelling residents aged 65–79 and ≥80 years in six European countries.
-
Burden of seasonal influenza in the Swiss adult population during the 2016/2017–2018/2019 influenza seasons Influenza Other Respir. Viruses (IF 4.4) Pub Date : 2023-11-24 Daniel Ammann, Jana Bilger, Matthew M. Loiacono, Susanne G. Oberle, Andreas Dounas, Oriol Manuel, Mark Pletscher
Evidence on the burden of seasonal influenza in Switzerland is scarce, yet it is critical for the design of effective prevention and control measures. The objective of this study was to assess influenza-related resource utilization, health care expenditures and quality-adjusted life-years (QALYs) lost in Switzerland across the 2016/2017–2018/2019 influenza seasons.
-
Inpatient burden of respiratory syncytial virus in children ≤2 years of age in Germany: A retrospective analysis of nationwide hospitalization data, 2019–2022 Influenza Other Respir. Viruses (IF 4.4) Pub Date : 2023-11-24 Moritz Wick, Anahita Poshtiban, Rolf Kramer, Mathieu Bangert, Matthias Lange, Martin Wetzke, Oliver Damm
Respiratory syncytial virus (RSV) causes respiratory tract disease in seasonal waves, primarily in infants and young children. This study aims to quantify the number of RSV-related hospitalizations in children ≤2 years of age and to determine corresponding resource use and costs in Germany.
-
SARS-CoV-2 infection and effects of age, sex, comorbidity, and vaccination among older individuals: A national cohort study Influenza Other Respir. Viruses (IF 4.4) Pub Date : 2023-11-21 Mai A. Mahmoud, Houssein H. Ayoub, Peter Coyle, Patrick Tang, Mohammad R. Hasan, Hadi M. Yassine, Asmaa A. Al Thani, Zaina Al-Kanaani, Einas Al-Kuwari, Andrew Jeremijenko, Anvar Hassan Kaleeckal, Ali Nizar Latif, Riyazuddin Mohammad Shaik, Hanan F. Abdul-Rahim, Gheyath K. Nasrallah, Mohamed Ghaith Al-Kuwari, Adeel A. Butt, Hamad Eid Al-Romaihi, Mohamed H. Al-Thani, Abdullatif Al-Khal, Roberto Bertollini
We investigated the contribution of age, coexisting medical conditions, sex, and vaccination to incidence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and of severe, critical, or fatal COVID-19 in older adults since pandemic onset.
-
Seasonal and inter-seasonal RSV activity in the European Region during the COVID-19 pandemic from autumn 2020 to summer 2022 Influenza Other Respir. Viruses (IF 4.4) Pub Date : 2023-11-20 Margaux M. I. Meslé, Mary Sinnathamby, Piers Mook, , Richard Pebody
The emergence of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in early 2020 and subsequent implementation of public health and social measures (PHSM) disrupted the epidemiology of respiratory viruses. This work describes the epidemiology of respiratory syncytial virus (RSV) observed during two winter seasons (weeks 40–20) and inter-seasonal periods (weeks 21–39) during the pandemic
-
Transmissibility of severe acute respiratory syndrome coronavirus 2 among household contacts of coronavirus disease 2019-positive patients: A community-based study in India Influenza Other Respir. Viruses (IF 4.4) Pub Date : 2023-11-17 Aswathy Sreedevi, Ahmad Mohammad, Mini Satheesh, Anuja Ushakumari, Anil Kumar, Geetha Raveendran, Saritha Narayankutty, Soumya Gopakumar, Anisur Rahman, Sachin David, Minu Maria Mathew, Prem Nair
This study identified the risk factors for severe acute respiratory syndrome coronavirus 2 infection among household contacts of index patients and determined the incubation period (IP), serial interval, and estimates of secondary infection rate in Kerala, India.
-
Transmissibility and severity of COVID-19 in a humanitarian setting: First few X investigation of cases and contacts in Juba, South Sudan, 2020 Influenza Other Respir. Viruses (IF 4.4) Pub Date : 2023-11-17 Richard Lino Loro Lako, Niamh Meagher, Joseph Francis Wamala, John Ndyahikayo, Ayesheshem Ademe Tegegne, Olushayo Oluseun Olu, David J. Price, Soatiana Rajatonirina, Elise Farley, Joseph Chukwudi Okeibunor, Valerie Ann Mize
The first few ‘X’ (FFX) studies provide evidence to guide public health decision-making and resource allocation. The adapted WHO Unity FFX protocol for COVID-19 was implemented to gain an understanding of the clinical, epidemiological, virological and household transmission dynamics of the first cases of COVID-19 infection detected in Juba, South Sudan.
-
The burden of the coronavirus disease 2019 virus infection in Burkina Faso: Results from a World Health Organization UNITY population-based, age-stratified sero-epidemiological investigation Influenza Other Respir. Viruses (IF 4.4) Pub Date : 2023-11-17 Samiratou Ouedraogo, Isidore Tiandiogo Traoré, Dramane Kania, Nongodo Firmin Kaboré, Ariane Mamguem Kamga, Hermann Badolo, Mimbouré Yara, Guillaume Sanou, Amariane Koné, Samdapawindé Thérèse Kagoné, Esperance Ouédraogo, Blahima Konaté, Rachel Médah, Nathalie de Rekeneire, Armel Poda, Arnaud Eric Diendere, Boukary Ouédraogo, Oumar Billa, Gilles Paradis, Halidou Tinto, Tienhan Sandrine Dabakuyo-Yonli
This study aimed to estimate the anti-SARS-CoV-2 antibody seroprevalence in the general population of Bobo-Dioulasso and Ouagadougou (Burkina Faso).
-
Monitoring the quality of SARS-CoV-2 virus detection in molecular diagnostic laboratories in the Eastern Mediterranean Region during the COVID-19 pandemic Influenza Other Respir. Viruses (IF 4.4) Pub Date : 2023-11-17 Luke W. Meredith, Mustafa Aboualy, Rachel Ochola, Mehmet Ozel, Abdinasir Abubakar, Amal Barakat
The COVID-19 pandemic placed unprecedented stress on laboratories in the Eastern Mediterranean Region. Building on existing capacity for influenza diagnostics, countries introduced COVID-19 diagnostic support to ~100% regional coverage. A key challenge during the expansion was maintaining quality testing in laboratories, ensuring that correct results were shared with medical facilities.
-
Descriptive epidemiology of SARS-CoV-2 Beta (B.1.351) variant cases in England, December 2020 to June 2022 Influenza Other Respir. Viruses (IF 4.4) Pub Date : 2023-11-15 Mary A. Sinnathamby, Asad Zaidi, Katherine A. Twohig, Shirin Aliabadi, Nurin Abdul Aziz, Natalie Groves, Eileen Gallagher, Simon Thelwall, Gavin Dabrera
The emergence of the SARS-CoV-2 Beta (B.1.351) variant in November 2020 raised concerns of increased transmissibility and severity. We describe the epidemiology of 949 confirmed SARS-CoV-2 Beta variant cases in England, identified between December 2020 and June 2022. Most cases were detected in the first 3 months. A total of 10 deaths (1.1%; 10/949) were identified among all cases and of those with
-
Antibiotic prescription for outpatients with influenza and subsequent hospitalisation: A cohort study using insurance data Influenza Other Respir. Viruses (IF 4.4) Pub Date : 2023-11-12 Hiroshi Yokomichi, Mie Mochizuki, Joseph Jonathan Lee, Reiji Kojima, Sayaka Horiuchi, Tadao Ooka, Zentaro Yamagata
Whether prophylactic administration of antibiotics to patients with influenza reduces the hospitalisation risk is unknown. We aimed to examine the association between antibiotic prescription in outpatients with influenza infection and subsequent hospitalisation.
-
Influenza D virus was not detected among prospectively studied swine farm in multiple provinces of China Influenza Other Respir. Viruses (IF 4.4) Pub Date : 2023-11-12 Sajid Umar, Mai-Juan Ma, Gregory C. Gray
Influenza viruses now consists of four species: influenza A virus (IAV), influenza B virus (IBV), influenza C virus (ICV), and influenza D virus (IDV) within the family Orthomyxoviridae. IDV was first discovered in April 2011 in the state of Oklahoma (U.S.A.) among pigs with respiratory illness.1 Since then, IDV has been detected in multiple countries and in an increasing number of animal species including
-
Presence of SARS-CoV-2 virus in wastewater in the Kingdom of Bahrain during the COVID-19 pandemic Influenza Other Respir. Viruses (IF 4.4) Pub Date : 2023-11-13 Afaf Merza Mohamed, Ebrahim Matar, Hasan M. Isa, Ahmed K. Moosa, Wafa Fawzi Hasan, Amjad Ghanem Mohamed, Adel Salman Al Sayyad, Maryam Y. Sanad, Maryam Alhajeri, Najat Abu Alfatah, Qasim M. Alaraibi
Several countries, including Bahrain, used wastewater surveillance for disease activity monitoring. This study aimed to determine the presence of SARS-CoV-2 in untreated wastewater and to correlate it with the disease spread.
-
Implementation and expansion of laboratory capacity for molecular diagnostics in response to COVID-19 and preparedness for other emerging infectious diseases in the Islamic Emirate of Afghanistan Influenza Other Respir. Viruses (IF 4.4) Pub Date : 2023-11-12 Murad Momin Khan, Mohamed Mostafa Tahoun, Luke W. Meredith, Amal Barakat, Hafizullah Safi, Ahmed Nasir Hanifi, Mohammad Omar Mashal, Abdul Wahid Amiri, Alaa Abouzeid
Afghanistan experienced various outbreaks before and during the Covid-19 pandemic, including dengue, Crimean Congo hemorrhagic fever (CCHF), measles, and acute watery diarrhea (AWD). Diagnostic and surveillance support was limited, with only the Central Public Health Laboratory equipped to handle outbreak responses. This article highlights initiatives taken to improve diagnostic capabilities for COVID-19
-
Interactions among acute respiratory viruses in Beijing, Chongqing, Guangzhou, and Shanghai, China, 2009–2019 Influenza Other Respir. Viruses (IF 4.4) Pub Date : 2023-11-12 Zachary J. Madewell, Li-Ping Wang, Natalie E. Dean, Hai-Yang Zhang, Yi-Fei Wang, Xiao-Ai Zhang, Wei Liu, Wei-Zhong Yang, Ira M. Longini, George F. Gao, Zhong-Jie Li, Li-Qun Fang, Yang Yang
A viral infection can modify the risk to subsequent viral infections via cross-protective immunity, increased immunopathology, or disease-driven behavioral change. There is limited understanding of virus–virus interactions due to lack of long-term population-level data.
-
From respiratory diseases to nervous system disorders: Unraveling the certified causes of influenza-associated deaths in Poland from 2000 to 2019 Influenza Other Respir. Viruses (IF 4.4) Pub Date : 2023-11-12 Marcin Piotr Walkowiak, Dariusz Walkowiak
This study aims to accurately estimate influenza-associated deaths in Poland and their certified cause of death, due to significant discrepancies between official numbers and expected impact.
-
Seroprevalence of SARS-CoV-2 antibodies and associated risk factors during the second wave of infection in a university community in Cameroon Influenza Other Respir. Viruses (IF 4.4) Pub Date : 2023-11-12 René Ghislain Essomba, Albert Ngano Bayibeki, Abel Lissom, Pulchérie Thérèse Ateba, Nassif Seni, Claude Ariane Nlozoa Fouda, Solange Berthe Diwandja Mbitock, Normand David Ebonda, Sylvie Delphine Afana, Siméon Akame, Adelphe Anyang Tembu, Modeste Romuald Ngamaleu, Bernard Christel Bihonba Bimai, Ousmane Kabo, Philipe Salomon Nguwoh, Christian Taheu Ngounouh, Moise Christian Junior Meka, Michel Kengne
The COVID-19 pandemic has caused a public health emergency in all sectors of society, including universities and other academic institutions in Cameroon. However, little is known concerning the real prevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections among student communities during the second wave of infection in Cameroon. This study aimed to estimate SARS-CoV-2 antibodies
-
Issue Information Influenza Other Respir. Viruses (IF 4.4) Pub Date : 2023-11-07
No abstract is available for this article.